SCHEMBL5970039

SCHEMBL5970039

COc1ccc(CCNc2ccc(-c3nc4[nH]c(=O)[nH]c(=O)c4[nH]3)cn2)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.47
▸ RIN1 Q13671 1/20 0.47
▸ LIG1 P18858 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ ADORA2B P29275 1/20 0.43
▸ PTGDR Q13258 9/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ JAK1 P23458 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5970460 0.91 NPC1 (0.48) LIG1HTTADORA2BHDAC1KMT2A
SCHEMBL5970239 0.82 ADORA2B (0.51) SMN1; SMN2ADORA2B
SCHEMBL5970324 0.82 ATM (0.47) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5970144 0.79 ADORA2B (0.47) LIG1ADORA2BKMT2AMEN1
SCHEMBL5970230 0.77 ADORA2B (0.48) ADORA2BHDAC1NPC1RAB9A
SCHEMBL1497237 0.77 ADORA2B (0.68) CYP3A4SMN1; SMN2ADORA2B
SCHEMBL5970512 0.77 ADORA2B (0.45) ADORA2BJAK1
SCHEMBL5971137 0.77 ATM (0.51) ABL1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5970527 0.76 ADORA2B (0.57) LIG1CYP3A4ADORA2BKMT2AMEN1
SCHEMBL5970374 0.75 ADORA2B (0.48) LIG1SMN1; SMN2ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658291-A2 SUBSTITUTED 8-HETEROARYL XANTHINES Adenosine Therapeutics, LLC (US) 2006-05-24 — — EP claimed
WO-2005021548-A2 SUBSTITUTED 8-HETEROARYL XANTHINES ADENOSINE THERAPEUTICS, LLC (US) 2005-03-10 — — WO claimed
EP-1658291-A2 SUBSTITUTED 8-HETEROARYL XANTHINES Adenosine Therapeutics, LLC (US) 2006-05-24 — — EP disclosed
WO-2005021548-A2 SUBSTITUTED 8-HETEROARYL XANTHINES ADENOSINE THERAPEUTICS, LLC (US) 2005-03-10 — — WO disclosed
Send feedback